Provided by Tiger Trade Technology Pte. Ltd.

ALLURION TECHNOLOGIES

1.14
+0.06005.56%
Post-market: 1.140.00000.00%16:10 EST
Volume:22.17K
Turnover:24.78K
Market Cap:13.97M
PE:-0.15
High:1.17
Open:1.08
Low:1.07
Close:1.08
52wk High:5.78
52wk Low:0.9500
Shares:12.26M
Float Shares:5.86M
Volume Ratio:0.46
T/O Rate:0.38%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-7.7600
EPS(LYR):-3.2031
ROE:--
ROA:-71.87%
PB:-0.17
PE(LYR):-0.36

Loading ...

BRIEF-Allurion Announces Partnership To Offer Combination Therapy With Mounjaro® (Tirzepatide) At Discounted Prices

Reuters
·
Feb 03

Allurion Partners with Bionut to Offer Discounted Mounjaro for Combination Weight Loss Therapy

Reuters
·
Feb 03

Allurion Technologies Inc - Announces Partnership With Bionut and Farmastar in Argentina

THOMSON REUTERS
·
Feb 03

Allurion Announces Partnership to Offer Combination Therapy With Mounjaro® (Tirzepatide) at Discounted Prices

THOMSON REUTERS
·
Feb 03

BUZZ-U.S. STOCKS ON THE MOVE-US natgas companies

Reuters
·
Jan 26

Allurion Technologies files to sell 5.99M shares of common stock for holders

TIPRANKS
·
Jan 10

Allurion Technologies Holdings Inc. Held Annual Shareholder Meeting

Reuters
·
Dec 20, 2025

BRIEF-Allurion Reports 23% Weight Loss, 14% Lean Mass Gain On Combining Program With Tirzepatide

Reuters
·
Nov 26, 2025

BUZZ-U.S. STOCKS ON THE MOVE-Applied Materials, CDW,  Kohl's

Reuters
·
Nov 25, 2025

Allurion reports initial results on Allurion Program, tirzepatide combination

TIPRANKS
·
Nov 25, 2025

Allurion Reports 23% Weight Loss and Increased Lean Mass With Combined Balloon and Low-Dose Tirzepatide Therapy

Reuters
·
Nov 25, 2025

Allurion Announces Initial Results on Combining the Allurion Program With Low-Dose Tirzepatide to Optimize Muscle Mass and Glp-1 Adherence

THOMSON REUTERS
·
Nov 25, 2025

Allurion Technologies Inc - Average Weight Loss of 23% With 14% Increase in Lean Body Mass

THOMSON REUTERS
·
Nov 25, 2025

Allurion Smart Capsule Delivers Superior Weight Loss and Body Composition in New Clinical Study

Reuters
·
Nov 20, 2025

Allurion Technologies Is Maintained at Neutral by Chardan Capital

Dow Jones
·
Nov 20, 2025

Allurion Announces Strategic Distribution Partnership With Prosurg Medical In Brazil To Pioneer New Approach Focused On Metabolically Healthy Weight Loss

Reuters
·
Nov 20, 2025

Allurion Technologies Signs Distribution Partnership with ProSurg Medical in Brazil

Reuters
·
Nov 18, 2025

Allurion Technologies Inc - Partnership to Increase Access to Allurion Program With Glp-1 Therapy

THOMSON REUTERS
·
Nov 18, 2025

Allurion Technologies Delays Quarterly Financial Filing

Reuters
·
Nov 18, 2025

Allurion Technologies Q3 revenue beats expectations

Reuters
·
Nov 12, 2025